Enclosed herewith is the outcome of the board meeting held on June 20, 2025. Kindly take the above information on record.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Wellness Limited held its board meeting on June 20, 2025, and approved two key decisions. First, Mr. Naveenakumar Kunjaru moved from Chairman and Managing Director to Managing Director, while Dr. Lalitkumar Anande became Chairman and Non-Executive Independent Director. Second, the company announced its entry into the diagnostic testing and tele-consultation segment, offering lab tests, home sample collection, video consultations, and digital access via a website and mobile app. The Indian diagnostics market is valued at Rs. 1.11 lakh crore and growing at 14% CAGR, with home sample collection expected to contribute 25-30% of this share. This expansion adds a new vertical to the company's existing wellness, nutraceutical, and herbal products portfolio, creating a vertically integrated preventive healthcare platform.
The foray into a high-growth diagnostics and tele-consultation segment could open a significant new revenue stream and positively influence stock sentiment, while the elevation of an independent director to Chairman strengthens corporate governance. Investors should watch for execution updates, customer adoption metrics, and any capex or funding details in coming quarters.